Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

1st Jul 2016 16:25

RNS Number : 0486D
GlaxoSmithKline PLC
01 July 2016
 

GlaxoSmithKline plc

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

 

In accordance with Disclosure and Transparency Rule 3.1.4R(1)(a), I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares ('ADSs') of GlaxoSmithKline plc (the 'Company').

 

On 30 June 2016, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £15.59 per Ordinary Share, and notional ADSs at a price of $42.37 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2016 to 30 June 2016:

 

 

Non Executive Director

Ordinary Shares

No. of ADSs

Sir Philip Hampton

2,806.286

 

Professor Sir Roy Anderson

581.302

 

Vindi Banga

2,140.172

 

Stacey Cartwright

461.033

 

Lynn Elsenhans

845.582

 

Judy Lewent

436.213

 

Urs Rohner

541.212

 

Jesse Goodman was appointed to the Board with effect from 1 January 2016. In accordance with the share allocation arrangements for Non-Executive Directors, 25% of Jesse Goodman's fees will be retained and will be reinvested in the Company's ADSs at a future date, to be mutually agreed.

 

The Company and the Non-Executive Directors were advised of these allocations on 1 July 2016.

 

 

V A Whyte

Company Secretary

 

1 July 2016

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEFLFBQDFLBBZ

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77